CPIX - Company ID 0001087294
The table below shows CUMBERLAND PHARMACEUTICALS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2025 | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.86M | $11.01M | $15.20M | $16.09M | $17.46M | $17.34M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $13.42M | $14.26M | $10.43M | $10.32M | $11.31M | $11.62M |
| Inventory | $29.93K | $5.45M | $2.93M | $3.22M | $4.51M | $4.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $33.64M |
| $32.79M |
| $29.94M |
| $31.21M |
| $35.24M |
| $35.58M |
| Property, plant & equipment | $248.81K | $237.38K | $293.38K | $297.79K | $312.03K | $337.09K |
| Goodwill | - | $914.00K | $914.00K | $914.00K | $914.00K | $914.00K |
| Total assets | $62.88M | $71.00M | $65.90M | $67.91M | $76.75M | $78.52M |
| Accounts payable | $19.55M | $16.54M | $13.83M | $13.45M | $12.06M | $12.51M |
| Total current liabilities | $35.19M | $34.49M | $24.31M | $23.97M | $31.09M | $24.76M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $45.77M | $49.69M | $40.10M | $40.23M | $52.28M | $52.49M |
| Retained earnings | -$34.37M | -$30.09M | -$25.39M | -$23.45M | -$22.06M | -$20.52M |
| Total equity | $17.44M | $21.64M | $26.12M | $27.99M | $24.78M | $26.35M |